Wells Fargo & Company »

Larimar Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $72k 9.4k 7.59
2023-12-31 $36k 8.0k 4.55
2023-09-30 $25k 6.4k 3.95
2023-06-30 $31k 9.8k 3.13
2022-12-31 $814 197 4.13
2022-09-30 $0 98 0.00
2022-06-30 $0 78 0.00
2020-12-31 $120k 5.6k 21.41
2020-09-30 $999 79 12.66
2020-06-30 $0 16 0.00